4//SEC Filing
MIGNONE ROBERTO 4
Accession 0001193125-25-274286
CIK 0000818686other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 4:15 PM ET
Size
6.9 KB
Accession
0001193125-25-274286
Insider Transaction Report
Form 4
MIGNONE ROBERTO
Director
Transactions
- Sale
Ordinary Shares
2025-11-06$24.11/sh−200,000$4,821,880→ 495,000 total(indirect: [see footnote])
Holdings
- 105,315
Ordinary Shares
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.0050 to $24.2450, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The 495,000 Ordinary Shares disclosed in Table I of this Form 4 are held of record by Swiftcurrent Master Fund Ltd. (the "Fund"). Bridger Management, LLC is the investment adviser to the Fund and Mr. Mignone is the manager of Bridger Management, LLC. By reason of the provisions of Rule 16a-1(a)(1) under the Securities Exchange Act of 1934, as amended, Mr. Mignone may be deemed to beneficially own the Ordinary Shares held of record by the Fund. Mr. Mignone disclaims beneficial ownership of the Ordinary Shares held of record by the Fund except to the extent of his indirect pecuniary interest therein and this report shall not be deemed an admission that Mr. Mignone is the beneficial owner of the Ordinary Shares held of record by the Fund for purposes of Section 16, or for any other purpose.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001258394
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 4:15 PM ET
- Size
- 6.9 KB